Clinical trial
Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole ( a Prospective Cohort Study)
NCT07333326 is registered in ClinicalTrials.gov with Minia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole ( a Prospective Cohort Study)
- Lead sponsor
- Minia University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 10, 2026
- Completion date
- February 10, 2027
- Enrollment
- 175 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
complete hydatiform mole, gestational trophoblastic neoplasia